Status:
COMPLETED
Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
Lead Sponsor:
Allergan
Conditions:
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to assess the safety and efficacy of Brimonidine/Timolol Fixed Combination in patients with glaucoma or ocular hypertension
Eligibility Criteria
Inclusion
- Clinical diagnosis of ocular hypertension or chronic glaucoma in both eyes
- Patient requires IOP-lowering drug in both eyes
Exclusion
- Uncontrolled medical condition
- Contraindication to beta-adrenoceptor antagonist or brimonidine therapy
Key Trial Info
Start Date :
December 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2001
Estimated Enrollment :
586 Patients enrolled
Trial Details
Trial ID
NCT00332436
Start Date
December 1 1999
End Date
November 1 2001
Last Update
May 30 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Louisville, Kentucky, United States